rs144538512
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_002951.5(RPN2):c.188C>T(p.Ala63Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 1,614,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002951.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPN2 | NM_002951.5 | c.188C>T | p.Ala63Val | missense_variant | 2/17 | ENST00000237530.11 | NP_002942.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPN2 | ENST00000237530.11 | c.188C>T | p.Ala63Val | missense_variant | 2/17 | 1 | NM_002951.5 | ENSP00000237530 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000485 AC: 122AN: 251468Hom.: 0 AF XY: 0.000500 AC XY: 68AN XY: 135912
GnomAD4 exome AF: 0.000229 AC: 335AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.000243 AC XY: 177AN XY: 727228
GnomAD4 genome AF: 0.000427 AC: 65AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.188C>T (p.A63V) alteration is located in exon 2 (coding exon 2) of the RPN2 gene. This alteration results from a C to T substitution at nucleotide position 188, causing the alanine (A) at amino acid position 63 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Congenital disorder of glycosylation Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 13, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at